R01 HL063290/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	4
2009	5
2010	2
2011	3
2012	4
2013	6
2014	1
2015	2
2016	1
2024	0

1

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Zlokovic BV. Zlokovic BV. Nat Rev Neurosci. 2011 Nov 3;12(12):723-38. doi: 10.1038/nrn3114. Nat Rev Neurosci. 2011. PMID: 22048062 Free PMC article. Review.

2

Activated protein C: biased for translation.

Griffin JH, Zlokovic BV, Mosnier LO. Griffin JH, et al. Blood. 2015 May 7;125(19):2898-907. doi: 10.1182/blood-2015-02-355974. Epub 2015 Mar 30. Blood. 2015. PMID: 25824691 Free PMC article. Review.

3

Protein C anticoagulant and cytoprotective pathways.

Griffin JH, Zlokovic BV, Mosnier LO. Griffin JH, et al. Int J Hematol. 2012 Apr;95(4):333-45. doi: 10.1007/s12185-012-1059-0. Epub 2012 Apr 5. Int J Hematol. 2012. PMID: 22477541 Free PMC article. Review.

4

Cytoprotective-selective activated protein C therapy for ischaemic stroke.

Mosnier LO, Zlokovic BV, Griffin JH. Mosnier LO, et al. Thromb Haemost. 2014 Nov;112(5):883-92. doi: 10.1160/TH14-05-0448. Epub 2014 Sep 18. Thromb Haemost. 2014. PMID: 25230930 Free PMC article. Review.

5

Cytoprotective protein C pathways and implications for stroke and neurological disorders.

Zlokovic BV, Griffin JH. Zlokovic BV, et al. Trends Neurosci. 2011 Apr;34(4):198-209. doi: 10.1016/j.tins.2011.01.005. Epub 2011 Feb 25. Trends Neurosci. 2011. PMID: 21353711 Free PMC article. Review.

6

Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Sagare AP, Deane R, Zlokovic BV. Sagare AP, et al. Pharmacol Ther. 2012 Oct;136(1):94-105. doi: 10.1016/j.pharmthera.2012.07.008. Epub 2012 Jul 20. Pharmacol Ther. 2012. PMID: 22820095 Free PMC article. Review.

7

Central nervous system pericytes in health and disease.

Winkler EA, Bell RD, Zlokovic BV. Winkler EA, et al. Nat Neurosci. 2011 Oct 26;14(11):1398-1405. doi: 10.1038/nn.2946. Nat Neurosci. 2011. PMID: 22030551 Free PMC article.

8

2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.

Griffin JH, Mosnier LO, Fernández JA, Zlokovic BV. Griffin JH, et al. Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2143-2151. doi: 10.1161/ATVBAHA.116.308038. Epub 2016 Oct 6. Arterioscler Thromb Vasc Biol. 2016. PMID: 27758767 Free PMC article. Review.

9

Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers.

Lyden P, Levy H, Weymer S, Pryor K, Kramer W, Griffin JH, Davis TP, Zlokovic B. Lyden P, et al. Curr Pharm Des. 2013;19(42):7479-85. doi: 10.2174/1381612819666131230131454. Curr Pharm Des. 2013. PMID: 24372304 Free PMC article. Clinical Trial.

10

Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity.

Guo H, Wang Y, Singh I, Liu D, Fernández JA, Griffin JH, Chow N, Zlokovic BV. Guo H, et al. J Neurochem. 2009 Apr;109(1):116-24. doi: 10.1111/j.1471-4159.2009.05921.x. Epub 2009 Jan 23. J Neurochem. 2009. PMID: 19166505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year